TP53 and non-small cell lung carcinoma: However the study of B. Deng et al. showed that the wound surface injection of recombinant adenoviral p53 gene (rAd-p53) has shown effective activity in preventing relapse or metastasis and improving both progression-free survival/overall survival after conventional surgery in patients with NSCLC [25].